Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Exocrine Pancreatic Insufficiency Market from 2024 to 2025?

In recent times, the market size for exocrine pancreatic insufficiency has seen robust growth. It is projected to expand from $2.59 billion in 2024 to $2.76 billion in 2025 with a compound annual growth rate (CAGR) of 6.6%. The expansion in the past period can be linked to a heighten diagnosis and awareness, an increase in digestive disorders, the growing elderly population, pancreatic function deterioration, and a surge in gastrointestinal surgeries.

What Is the Projected Market Size of the Exocrine Pancreatic Insufficiency Market?

The market for exocrine pancreatic insufficiency is forecasted to experience robust expansion in the coming years. The market’s estimation is predicted to reach $3.58 billion by 2029 with a CAGR of 6.7%. The projected growth within this period is due to factors including heightened recognition and screening, growth of the elderly population, an increase in chronic diseases, better access to healthcare for patients, and advances in research and development for digestive health. Key trends anticipated within this period are the adoption of telehealth and digital health solutions, combined research initiatives, a focus on pediatric epi, regulatory progress and fast-track designations, market growth in emerging economies, and improvements in healthcare infrastructure.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp

Who are the Major Competitors in the Exocrine Pancreatic Insufficiency Market Outlook?

Major companies operating in the exocrine pancreatic insufficiency market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Nestle Health Science S.A., Allergan PLC, Chiesi Farmaceutici S.p.A., Wockhardt Ltd., Amryt Pharma PLC, Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, Aimmune Therapeutics Inc., Digestive Care Inc., Enzymedica Inc., Vivus Inc., Alcresta Therapeutics Inc., Cilian AG, Perseo Pharma AG, Enzyme Development Corporation, First Wave BioPharma Inc., Synspira Therapeutics

What Is Fueling Growth in the Exocrine Pancreatic Insufficiency Market?

The exocrine pancreatic insufficiency market’s progression is predicted to be fueled by an increase in chronic illnesses. Chronic diseases, which persist for extended periods typically over three months, often increase the chances of secondary complications like exocrine pancreatic insufficiency. Management of chronic ailments via medical interventions and therapeutic strategies can potentially increase life spans of affected individuals. For instance, a report from the World Health Organization in September 2023 stated that 41 million annual deaths, 74% of them due to non-communicable or chronic diseases globally. This surge in chronic diseases is anticipated to bolster the exocrine pancreatic insufficiency market’s growth. Advancements in the Exocrine Pancreatic Insufficiency Market are expected to be propelled by the escalating diabetes epidemic. Diabetes, a chronic health issue that arises when the body isn’t producing enough insulin or misuses it, often results in excessive blood sugar in the bloodstream due to insufficient insulin or cell insensitivity to insulin. Pancreatic enzyme replacement treatment (PERT) is needed for exocrine pancreatic insufficiency (EPI) to ensure the production of sufficient digestive enzymes to maintain insulin levels. For example, the Institute for Health Metrics and Evaluation predicted in June 2023 that global diabetes cases would increase to 1.3 billion by 2050, from 529 million in 2022. Thus, the increase in diabetes cases is predicted to fuel the growth of the exocrine pancreatic insufficiency market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13107&type=smp

Which Exocrine Pancreatic Insufficiency Market Segments Are Growing the Fastest?

The exocrine pancreatic insufficiency market covered in this report is segmented –

1) By Treatment: Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Other Treatments

2) By Diagnosis: Imaging Tests, Computed Tomography (CT) Scan, Abdominal Ultrasound, Secretin Pancreatic Function Test, Fecal Fat Test, Fecal Elastase Test (FE-1), Other Types

3) By Symptoms: Abdominal Pain, Constipation, Diarrhea, Fatty Stools, Weight Loss, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End Users: Hospitals, Specialty Clinics, Homecare

Subsegments:

1) By Nutritional Management: Dietary Modifications, Nutritional Supplements

2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules, Non-Enteric-Coated Capsules, Powder Formulations

3) By Other Treatments: Medications, Surgical Interventions, Supportive Therapies

Which Industry Trends Are Shaping the Future of the Exocrine Pancreatic Insufficiency Market?

Leading firms in the exocrine pancreatic insufficiency market are focusing on building patient advocacy groups such as comprehensive nutritional advice programs, with a primary goal of improving awareness, education, and management for those affected by the condition. These programmes encompass a holistic strategy that offers dietary suggestions tailored to each individual’s health conditions, needs, and lifestyle. They stress on meal planning, education, and implementing sustainable practices to encourage total health and well-being. For instance, Nestlé Health Science, a nutrition company based in Switzerland, introduced a GLP-1 nutrition support platform in June 2024. This platform by Nestlé Health Science provides bespoke nutritional advice and professional guidance for those using GLP-1 medications. It emphasizes muscle conservation, gut health, and overall wellness. The platform is designed to aid its users in their weight management journey by considering individual dietary requirements and promoting community support.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-global-market-report

Which Countries Are Leading the Exocrine Pancreatic Insufficiency Market?

North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13107

This Report Delivers Insight On:

1. How big is the exocrine pancreatic insufficiency market, and how is it changing globally?

2. Who are the major companies in the exocrine pancreatic insufficiency market, and how are they performing?

3. What are the key opportunities and risks in the exocrine pancreatic insufficiency market right now?

4. Which products or customer segments are growing the most in the exocrine pancreatic insufficiency market?

5. What factors are helping or slowing down the growth of the exocrine pancreatic insufficiency market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model